The Futuregrowth Development Equity Fund (DEF), on behalf of its clients, has recently invested in a pioneering Cape Town-based biomedical engineering start-up, Impulse Biomedical.

Impulse’s flagship device, the ZiBiPen, could revolutionise the emergency treatment of life-threatening anaphylaxis. The device was developed by two passionate engineering graduates, Gokul Nair and Giancarlo Beukes, while completing their masters’ degrees in biomedical engineering at the University of Ca...